Activate is building a new generation of innovators that can redefine how technology serves society and sustains the planet. We partner with funders and leading research institutions to provide a new path for top scientists and engineers to transform their discoveries into world-changing products. Our fellows are building transformative energy, climate, and manufacturing technologies across two locations: Activate Boston and Cyclotron Road, a program of Lawrence Berkeley National Laboratory. Fellows receive funding, access to world-class research facilities, entrepreneurial mentorship, networking, and education.
Urban (controlled) agriculture is on the rise! Vertical and Container farms are popping up here and there and there is increasing need to make urban agriculture more sustainable. AdaViv is a hardware-enabled, predictive agriculture company. Keeping “24/7 eyes on the plants”, our sensing and AI + computer vision uncovers hidden plant biometrics and translates data into actionable insights for growers. From disease prevention to rapid experimentation, improving yields and quality optimization, AdaViv helps producers grow smarter. Founded by an interdisciplinary team of MIT researchers and alumni, AdaViv recently emerged from MIT Delta V, the capstone entrepreneurship accelerator at MIT , and the MIT DesignX accelerator. In 2018, AdaViv was selected as one of the first grantees of Microsoft AI for Earth.
Almond is unlocking a world of transactions between individuals and financial institutions across the globe. Through turnkey API solutions leveraging Web 3.0 technology, Almond allows for greater global interoperability between financial institutions and individuals with speed and cost efficiency.
Biobot Analytics is a wastewater epidemiology company that is transforming wastewater infrastructure into public health observatories. Its wastewater monitoring technology analyzes urine and stool samples to create a health database that is independent of hospital reporting systems, free from societal biases affecting who can and can’t seek care,and most importantly, rapidly adaptable to new and emerging public health threats.